Vir Biotechnology
VIR
VIR
210 hedge funds and large institutions have $2.2B invested in Vir Biotechnology in 2022 Q2 according to their latest regulatory filings, with 51 funds opening new positions, 75 increasing their positions, 55 reducing their positions, and 42 closing their positions.
New
Increased
Maintained
Reduced
Closed
Holders
210
Holders Change
+7
Holders Change %
+3.45%
% of All Funds
3.55%
Holding in Top 10
2
Holding in Top 10 Change
-2
Holding in Top 10 Change %
-50%
% of All Funds
0.03%
New
51
Increased
75
Reduced
55
Closed
42
Calls
$11.6M
Puts
$6.66M
Net Calls
+$4.9M
Net Calls Change
-$1.51M
Top Buyers
| 1 |
1
BlackRock
New York
|
$326M |
| 2 |
2
State Street
Boston,
Massachusetts
|
$141M |
| 3 |
3
Pacer Advisors
Malvern,
Pennsylvania
|
$20M |
| 4 |
4
Morgan Stanley
New York
|
$27.5M |
| 5 |
5
Renaissance Technologies
New York
|
$14.3M |
